{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:34:06Z","timestamp":1783578846445,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>The prognostic implications of non-sustained ventricular tachycardia (NSVT) and their significance as therapeutic targets in patients without prior sustained ventricular arrhythmias remain undetermined. The aim of this study was to investigate the prognostic significance of asymptomatic NSVT in patients who had primary prevention implantable cardioverter-defibrillator (ICD) implantation due to ischemic or non-ischemic cardiomyopathy (ICM, NICM).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We enrolled 157 consecutive primary prevention ICD patients without previous appropriate ICD therapy (AIT). Patients were allocated to two groups depending on the presence or absence of NSVT in a 6-month period prior to enrollment. The incidence of AIT and unplanned hospitalization due to decompensated heart failure (HF) were assessed during follow-up.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>In 51 patients (32%), precedent NSVT was documented. During a median follow-up of 1011\u00a0days, AIT occurred in 36 patients (23%) and unplanned HF hospitalization was observed in 32 patients (20%). In precedent NSVT patients, the incidence of AIT and unplanned HF hospitalization was significantly higher as compared to patients without precedent NSVT (AIT: 29\/51 [57%] vs. 7\/106 [7%], <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, log-rank; HF hospitalization: 16\/51 [31%] vs. 16\/106 [15%], <jats:italic>P<\/jats:italic>\u2009=\u20090.043, log-rank). Cox-regression demonstrated that precedent NSVT independently predicted AIT (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001). In subgroup analyses, precedent NSVT predicted AIT in both ICM and NICM (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>P<\/jats:italic>\u2009=\u20090.020), but predicted HF hospitalization only in patients with ICM (<jats:italic>P<\/jats:italic>\u2009=\u20090.0030).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Precedent non-sustained VT in patients with primary prevention ICDs is associated with subsequent appropriate ICD therapies, and is an independent predictor of unplanned heart failure hospitalizations in patients with ischemic cardiomyopathy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40001-020-0401-x","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T08:02:43Z","timestamp":1584432163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5302-2874","authenticated-orcid":false,"given":"Hisaki","family":"Makimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Zielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Clasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shqipe","family":"Gerguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Bejinariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Brinkmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"F\u00fcrnkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"401_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877\u201383.","journal-title":"N Engl J Med"},{"key":"401_CR2","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882\u2013900.","journal-title":"N Engl J Med"},{"key":"401_CR3","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"SG Priori","year":"2015","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekv\u00e5l TM, Spaulding C, Van Veldhuisen DJ, ESC Scientific Document Group. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36:2793\u2013867.","journal-title":"Eur Heart J"},{"key":"401_CR4","first-page":"e272","volume":"138","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, Deal BJ, Dickfeld T, Field ME, Fonarow GC, Gillis AM, Granger CB, Hammill SC, Hlatky MA, Joglar JA, Kay GN, Matlock DD, Myerburg RJ, Page RL. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation. 2018;138:e272\u2013e391.","journal-title":"Circulation"},{"key":"401_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/eurheartj\/eht451","volume":"35","author":"N Sood","year":"2014","unstructured":"Sood N, Ruwald AC, Solomon S, Daubert JP, McNitt S, Polonsky B, Jons C, Clyne CA, Zareba W, Moss AJ. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. Eur Heart J. 2014;35:106\u201315.","journal-title":"Eur Heart J"},{"key":"401_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009\u2013177.","journal-title":"N Engl J Med"},{"key":"401_CR7","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/0002-9149(86)90374-7","volume":"58","author":"JT Bigger Jr","year":"1986","unstructured":"Bigger JT Jr, Fleiss JL, Rolnitzky LM. Prevalence, characteristics and significance of ventricular tachycardia detected by 24-hour continuous electrocardiographic recordings in the late hospital phase of acute myocardial infarction. Am J Cardiol. 1986;58:1151\u201360.","journal-title":"Am J Cardiol"},{"key":"401_CR8","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/0002-9149(84)90522-8","volume":"53","author":"T Meinertz","year":"1984","unstructured":"Meinertz T, Hofmann T, Kasper W, Treese N, Bechtold H, Stienen U, Pop T, Leitner ER, Andresen D, Meyer J. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1984;53:902\u20137.","journal-title":"Am J Cardiol"},{"key":"401_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0002-9149(85)90317-0","volume":"55","author":"J Holmes","year":"1985","unstructured":"Holmes J, Kubo SH, Cody RJ, Kligfield P. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol. 1985;55:146\u201351.","journal-title":"Am J Cardiol"},{"key":"401_CR10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/0735-1097(95)00599-4","volume":"27","author":"JL Rouleau","year":"1996","unstructured":"Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, Gardner M, Stewart D, Plante S, Dupuis R, Lauzon C, Ferguson J, Mikes E, Balnozan V, Savard P. Myocardial infarction patients in the 1990s\u2014their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1990s;27:1119\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"401_CR11","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/01.CIR.96.6.1888","volume":"96","author":"AC Caruso","year":"1997","unstructured":"Caruso AC, Marcus FI, Hahn EA, Hartz VL, Mason JW. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Electrophysiologic study versus electromagnetic monitoring. Circulation. 1997;96:1888\u2013922.","journal-title":"Circulation"},{"key":"401_CR12","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.jacc.2013.02.046","volume":"61","author":"J Chen","year":"2013","unstructured":"Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (sudden cardiac death in heart failure trial). J Am Coll Cardiol. 2013;61:2161\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"401_CR13","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1111\/jce.13736","volume":"29","author":"M Kurt","year":"2018","unstructured":"Kurt M, Jathanna N, Babady M, Schmidt J, M\u00fcller P, Gerguri S, Clasen L, Bejinariu A, Kelm M, F\u00fcrnkranz A, Makimoto H. Avoiding inappropriate therapy of single-lead implantable cardioverter-defibrillator by using atrial-sensing electrodes. J Cardiovasc Electrophysiol. 2018;29:1682\u20139.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"401_CR14","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324:781\u20138.","journal-title":"N Engl J Med"},{"key":"401_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199507133330201","volume":"333","author":"SN Singh","year":"1995","unstructured":"Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med. 1995;333:77\u201382.","journal-title":"N Engl J Med"},{"key":"401_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","volume":"348","author":"AL Waldo","year":"1996","unstructured":"Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD investigators survival with oral d-sotalol. Lancet. 1996;348:7\u201312.","journal-title":"Lancet"},{"key":"401_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1056\/NEJMoa1609758","volume":"377","author":"L Shen","year":"2017","unstructured":"Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF, Dargie HJ, Granger CB, Kjekshus J, K\u00f8ber L, Latini R, Maggioni AP, Packer M, Pitt B, Solomon SD, Swedberg K, Tavazzi L, Wikstrand J, Zannad F, Zile MR, McMurray JJV. Declining risk of sudden death in heart failure. N Engl J Med. 2017;377:41\u201351.","journal-title":"N Engl J Med"},{"key":"401_CR18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.amjcard.2016.08.015","volume":"118","author":"J Jim\u00e9nez-Candil","year":"2016","unstructured":"Jim\u00e9nez-Candil J, Hern\u00e1ndez J, Perdiguero P, Mart\u00edn A, Mor\u00ed\u00f1igo J, Bravo L, Dur\u00e1n O, S\u00e1nchez PL. Prognostic significance of nonsustained ventricular tachycardia episodes occurring early after implantable cardioverter-defibrillator implantation among patients with left ventricular dysfunction. Am J Cardiol. 2016;118:1503\u201310.","journal-title":"Am J Cardiol"},{"key":"401_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1540-8159.2009.02566.x","volume":"33","author":"A Verma","year":"2010","unstructured":"Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2010;33:320\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"key":"401_CR20","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/jce.12456","volume":"25","author":"S Mittal","year":"2014","unstructured":"Mittal S, Aktas MK, Moss AJ, McNitt S, Kutyifa V, Steinberg JS, Zareba W. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. J Cardiovasc Electrophysiol. 2014;25:1082\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"401_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-019-00557-4","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhao S, Chen K, Hua W, Su Y, Chen S, Liang Z, Xu W, Zhang S. Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy. J Interv Card Electrophysiol. 2019. https:\/\/doi.org\/10.1007\/s10840-019-00557-4.","journal-title":"J Interv Card Electrophysiol"},{"key":"401_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacr\u00e9taz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS, VTACH Study Group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet. 2010;375:31\u201340.","journal-title":"Lancet"},{"key":"401_CR23","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","volume":"357","author":"VY Reddy","year":"2007","unstructured":"Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657\u201365.","journal-title":"N Engl J Med"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-020-0401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40001-020-0401-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-020-0401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:37:10Z","timestamp":1615941430000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-020-0401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1186\/s40001-020-0401-x","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in the context of the D\u00fcsseldorf University Device Registry (NCT03360227) and approved by the local institutional review board. All patients gave written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}